This page lists all pharmaceutical reports related to the field of Technology. The reports include market research reports and pipeline analyses.
- Drug Delivery Markets: Oral Delivery
- Cell Culture: The World Market for Media, Sera, and Reagents
- Biomarkers: A Market Briefing
- The Emerging Cancer Vaccine Market
- Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications
- Medical Imaging Markets: Magnetic Resonance
- The Protein Therapeutics Market: The Science and Business of a Growing Sector
- Needle-Free Drug Injection Systems and Safety Syringes: The Market for Alternatives to Traditional Needle-Based Delivery
- Transgenic Animals and Plants in Pharmaceutical Research and Manufacturing
- Drug Delivery Markets: Transdermal and Transmucosal Drug Delivery
- Drug Delivery: Oral, Implantable/Injectable, Pulmonary and Transdermal/Transmucosal Systems)
- The Future of Biotechnology Instrumentation
- Drug Delivery Markets: Pulmonary Delivery Systems
- Cancer Therapeutics: The Worldwide Market
- Cancer Stem Cells: Emerging Therapeutic, Diagnostics and Market Opportunities
- Molecular Diagnostics - Technologies, Markets and Companies
- Proteomics - Technologies, Markets and Companies
- Transdermal Drug Delivery - Technologies, Markets, and Companies
- Animal Biotechnology - Technologies, Markets and Companies
- Pain Therapeutics - Drugs, Markets and Companies
- Personalized Medicine - scientific and commercial aspects
- Drug Delivery in Cancer - technologies, markets and companies
- RNAi - technologies, markets and companies
- Gene Therapy - technologies, markets and companies
- Nanobiotechnologies- applications, markets and companies
- Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
- Cardiovascular Drug Delivery - technologies,markets and companies
- Biomarkers - technologies,markets and companies
- Cytogenetics - technologies,markets and companies
- Cell Therapy - Technologies, Markets and Companies
- Bioinformatics Markets
- Key Diagnostic Testing Markets
- Blood Gas Instrumentation Data Processing
- Cancer Diagnostic Testing World Markets
- Cardiac Marker Diagnostic Testing Markets
- Clinical Chemistry Analyzers
- DNA Sequencing and PCR Markets
- Cancer Therapeutics Markets
- High-Growth Diagnostic Tests Markets
- Genomics World Markets
- Microscopy Markets
- Molecular Diagnostics Markets
- Over-the-Counter Diagnostic Products World Markets
- Point of Care Diagnostic Testing - World Markets
- Women's Health: Diagnostic Tests
- Disposable Syringe Markets
- Point of Care Diagnostic Testing Sector Trends
- Pharmacogenomic Testing Markets
- Blood Glucose Testing and Diabetes Management
- Clinical Immunoanalyzer Markets
- Stem Cell Markets
- RNA Interference Markets
- Hematology Analyzer Instrumentation and Reagent Markets
- Clinical Laboratory Testing Volume 1: Reagents and Instruments
- Clinical Laboratory Testing Volume 2: Business Strategies
- Gene Expression Reagents Markets
- Therapeutic Proteins
- The World Market for In Vitro Diagnostics, 2005
- Nanomedicine 2006-2011
- The Global Biotech Report 2006: The rise of the Biotech blockbusters
- Bioinformatics Report - The forecasts and future of the market 2006-2011
- Therapeutic Monoclonal Antibodies, 2006-2011
- World market for cancer vaccines 2007-2012
- Stem Cells - Business opportunities and forecasts
- Theranostics Report 2007-2012
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Tissue Engineering and Stem Cell Technology Report 2007
- Age Related Macular Degeneration Market Outlook to 2012
- The Global Rheumatoid Arthritis Market Forecasts to 2012
- Cardiac Rhythm Management Devices World Markets: Defibrillators, Pacemakers and Leads
- Pipeline Insight: Hematological Malignancies - Pursuit for the next blockbuster intensifies
- Early Toxicology: Markets and Approaches
- DNA Sequencing Equipment and Services Markets
- Pipeline and Commercial Insight: Influenza Vaccines - Pandemic threat revitalizes the sector
- Psoriasis - Anti-TNF's lead another indication
- Multiple Sclerosis - Disease-modifying efficacy and side effects guide treatment
- Melanoma - Lucrative commercial opportunities persist
- Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities
- Biosimilars: Benchmarking the key players
- Therapeutic Cancer Vaccines - A turbulent path from bench to bedside
- Gynecological Cancers - Niche opportunities in advanced disease
- Biosimilars: Regulatory Issues - Europe continues to make strides while the US lags behind
- Inflammatory Bowel Disease-Competition Increases for the Biologics
- Non-Small Cell Lung Cancer
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Colorectal Cancer - Shaping the future dynamics of colorectal cancer management
- Molecular Targeted Cancer Therapies - More drugs on the market, more targets in the pipeline
- Supportive Care in Cancer Treatment - Some first-generation products proving difficult to dislodge
- Pipeline Insight: Insulins - Inhalable insulins unlikely to become blockbusters
- Rheumatoid Arthritis - Biologics battle up the treatment algorithm
- Pipeline Insight: Breast Cancer - A diverse and increasingly crowded pipeline
- Pipeline Insight: Cancer Overview Emerging Therapeutic and Commercial Opportunities
- From Blockbuster to Nichebuster
- Commercial Insight Top 20 Cancer Therapeutics
- Ovarian Cancer: Growing importance as secondary indication for targeted therapies
- Commercial Insight: Transplantation
- Strategies for Biogeneric Success
- Big Pharma' Turns to Biologics for Growth to 2010: Segmentation by drug technology
- Directed Molecular Evolution: Product lifecycle management for biologics
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Rheumatoid Arthritis
- Biotech in Autoimmune and Inflammatory Disease 2006
- Cancer Therapeutics 2006
- Biogenerics
- Cancer Vaccines Measuring Market Potential
- Acute Leukemias - Persistent unmet needs confer significant commercial opportunity
- Gastric Cancer - Targeted Therapies Home In On a Neglected Tumor Type
- Injectable Drug Delivery
- The Global Drug Delivery Market
- Antiviral Therapeutics - technologies, markets and companies
- Monoclonal Antibodies in Asthma
- Inhalable Drug Delivery
- Therapeutic Vaccines
- Disease Modification in Rheumatoid Arthritis - The Biologics Boom
- Juvenile Arthritis - A Niche In The Market
- Informatics in Drug Discovery: The Evolving Information Technology Marketplace
- Biogenerics 2005: A New Level of Complexity
- Pipeline Insight: Disease Modification In Rheumatoid Arthritis
- Optimizing Targeted Treatment in Cancer: Negotiating the Challenges to Success
- Tropical and Defense Vaccines - The Scared, the Weak and the Poor
- Pipeline Insight: Hematological malignancies - Targeted treatments & immunotherapy
- Monoclonal Antibody Therapies: Evolving into a $30 billion market
- Breast Cancer - Changing Treatment Paradigms for Local and Locally Advanced Breast Cancer
- Pipeline Insight: Cancer Vaccines and Cell Therapies
- Protein Drug Delivery
- DNA/RNA Therapies: Translating the Genome into a $1.2bn Market by 2010
- Psoriasis - Biologics Impact Treatment Regimes Across the Globe
- Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
- Endo Pharmaceuticals’ Lidoderm - Physician survey indicates increased use likely to fuel sales
- Systemic Lupus Erythematosus - On the Verge of a Breakthough
- Cancer Biomarkers: Enhancing diagnostic, therapeutic and developmental strategies
- Non-Small Cell Lung Cancer - Angiogenesis and signal transduction inhibitors to expand market
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Hepatocellular Carcinoma - Opportune indication for novel therapies
- Supportive Care in Oncology-Significant growth opportunities in new supportive care indications
- Drug Discovery Tools for High-Content Analysis
- Personalized Medicine
- Pipeline and Commercial Insight: Pediatric and Adolescent Vaccines
- Stakeholder Opinions: Primary Brain Cancer
- Cancer Vaccines Fantasy or Future?
- ARTHRITIS - Therapy Area Pipeline Report
- AUTOIMMUNE DISEASES - Therapy Area Pipeline Report
- CROHN DISEASE - Therapy Area Pipeline Report
- INFLAMMATION - Therapy Area Pipeline Report
- LUPUS - Therapy Area Pipeline Report
- RHEUMATOID ARTHRITIS - Therapy Area Pipeline Report
- ORGAN TRANSPLANTATION - Therapy Area Pipeline Report
- ANEMIA - Therapy Area Pipeline Report
- ULCERATIVE COLITIS - Therapy Area Pipeline Report
- ASTHMA - Therapy Area Pipeline Report
- BRONCHITIS - Therapy Area Pipeline Report
- BRONCHOSPASM - Therapy Area Pipeline Report
- CHRONIC OBSTRUCTIVE PULMONARY DISEASE - Therapy Area Pipeline Report
- COUGH - Therapy Area Pipeline Report
- NASAL CONGESTION - Therapy Area Pipeline Report
- MYELODYSPLASTIC SYNDROME - Therapy Area Pipeline Report
- LEUKEMIA - Therapy Area Pipeline Report
- BREAST CANCER - Therapy Area Pipeline Report
- GASTRIC CANCER - Therapy Area Pipeline Report
- HEAD AND NECK CANCER - Therapy Area Pipeline Report
- Autoimmune Market Outlook to 2012
- Innovative and Targeted Cancer Therapies: Key technologies, new applications and leading players
- Decoding Big Pharmas R&D Strategy in Oncology
- Monoclonal Antibodies: strategic analysis of the mAb market out to 2012
- Pipeline Insight: Cancer Overview - Increasing diversity offers both high risk and reward
- The Future of Biosimilars: Key opportunities & emerging therapies
- Biomarker Technology Platforms for Cancer Diagnoses and Therapies
- Global Smoking Cessation Market Analysis & Forecasts - Preparing for the First Blockbuster
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Drug Delivery Technology: Revolutionizing Diabetes Treatment
- Cell-Based Diagnostics: Technology, Applications, and Markets
- Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein, and other Microarrays
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Pipeline Insight: Molecular Targeted Cancer Therapies
- Stakeholder Insight: Renal Cancer - Targeted therapies rapidly take hold of market
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Immunomodulators: Therapeutic Needs, Pipelines and Prospects
- Translational Medicine in Biopharmaceutical Research and Development
- The CNS Market Outlook
- The Gastrointestinal Market Outlook to 2012
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Hepatitis B (HBV) - Commercial and Pipeline Insight
- Pediatric Drugs - the Worldwide Market
- Autoimmune Disorders and Transplant Rejection - The Potential of T-cells Targeted Therapeutics
- Rheumatoid arthritis - Emerging drug discovery targets and therapeutic candidates
- Asthma Therapeutics - New treatment options and emerging drug discovery targets
- BAFF (BLys) and APRIL: Emerging Targets for autoimmune disease & Cancer Therapeutics
- Injectable Drug Delivery: Probing the Route to Growth
- Commercial and Pipeline Perspectives: Lower GI Disorders - Remicade Leads Growth as Novel Biologics
- Commercial and Pipeline Perspectives: Rheumatoid Arthritis - Novel Biologics Drive Innovation
- Commercial Insight: Vaccines - Reaching Adulthood
- Inflammatory Bowel Disease - Efficacy and Compliance Key to Maximizing Patient Share
- Stakeholder Opinions: HIV Vaccines - The Emperor Has No Clothes
- Stakeholder Opinions: Malignant Melanoma - High Hurdles, High Rewards, Are Vaccines Only Skin Deep?
- Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
- The Future of Monoclonal Antibody Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011
- The Therapeutic Proteins Outlook To 2007: An analysis of leading products and late-stage pipeline developments
- Innovation in Drug Delivery: The future of nanotechnology and non-invasive protein delivery
- The Outlook For RNAi: Accelerating drug discovery and the development of RNAi therapeutics
- The Future Of Array Technologies: Impact on drug discovery and market growth in DNA, protein and tissue arrays
- The Future of Systems Biology: Emerging technologies and their impact on drug discovery, development and diagnostics
- The Emerging Drug Targets Outlook: An analysis of novel molecular targets to develop innovative new therapeutics
- Predictive ADME and Toxicology Strategies: Challenges and opportunities for in vivo, in vitro and in silico predictive technologies
- Opportunities in Stem Cell Research and Commercialization: Technology advances, regulatory impact and key players
- Commercial Opportunities from Biomarkers: Transforming drug discovery, clinical development and molecular diagnostics
- The Future of Metabolomics: Building competitive advantage in drug discovery, clinical development and diagnostics
- Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications
- Growth Factors: Indications, Products, and Markets
- Advanced Drug Delivery: Technologies, Applications, and Markets
- The World Market for Vaccines
- The Market for Lead Optimization Tools and Services: Applying the new "-omics" to enhance drug discovery
- The Emerging Cancer Vaccine Market
- Trends in Cell Therapeutics: Promise and Reality
- Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited
- Monoclonal Antibodies in Cancer Therapy: Emerging Products and Markets
- Immunomodulators in Cancer Therapy: Emerging Products and Markets
- Inhaled Insulin: A Market Briefing
- Gene Expression Profiling Markets
- Organ Transplant Immunosuppressive Markets
- Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market
- Non-Hodgkin's Lymphoma - Is there room to emulate Rituxan's success?
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Inflammatory Bowel Disease - Debate over early aggressive treatment continues
- Prostate Cancer - Hormone-refractory patients still waiting for treatment breakthroughs
- Head and Neck Cancer
- How to Conduct Clinical Trials in China
- Worldwide Market for Rheumatoid Arthritis and Lupus Treatments
- Alpha 1 Antitrypsin Deficiency
- Commercial Insight: Autoimmune Diseases - Market continues to prosper
- Innovations in Bioinformatics: Emerging tools for drug discovery and development
- The Cancer Market Outlook to 2012
- Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics
- Peripheral arterial disease: New pharmaceutical therapies to treat intermittent claudication symptoms, prevent ischemic events and to induce angiogenesis
- Cancer Cell Therapy Markets
- Companion Diagnostics in Personalized Medicine and Cancer Therapy
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- The Worldwide Market for Cancer Diagnostics
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- Vaccines: Market Analysis, Key Players, and Critical Trends
- Pipeline and Commercial Insight: Alzheimer's Disease
- Biologics in Infectious Diseases
- Systemic Lupus Erythematosus - Market set to enter era of biologic therapies
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- Pipeline Insight: Non-Small Cell Lung Cancer - emerging therapies
- Pipeline Insight: Breast Cancer - Targeted Therapies, New Cytotoxics and Vaccines
